REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 57 filers reported holding REPROS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,000 | +66.7% | 2,446 | -0.1% | 0.00% | – |
| Q2 2016 | $3,000 | -93.2% | 2,448 | -94.7% | 0.00% | – |
| Q1 2016 | $44,000 | -42.9% | 46,179 | -27.4% | 0.00% | – |
| Q4 2015 | $77,000 | -69.3% | 63,639 | +87.4% | 0.00% | – |
| Q3 2015 | $251,000 | -73.7% | 33,951 | -74.6% | 0.00% | -100.0% |
| Q2 2015 | $956,000 | +44.2% | 133,828 | +73.0% | 0.00% | – |
| Q1 2015 | $663,000 | +205.5% | 77,335 | +252.2% | 0.00% | – |
| Q4 2014 | $217,000 | +7.4% | 21,959 | +6.0% | 0.00% | – |
| Q3 2014 | $202,000 | -26.8% | 20,709 | +29.0% | 0.00% | – |
| Q2 2014 | $276,000 | -64.4% | 16,051 | -65.1% | 0.00% | -100.0% |
| Q1 2014 | $775,000 | -34.5% | 46,010 | -29.9% | 0.00% | 0.0% |
| Q4 2013 | $1,184,000 | +13.8% | 65,665 | +34.5% | 0.00% | 0.0% |
| Q3 2013 | $1,040,000 | – | 48,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
| Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
| GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
| Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
| Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
| Renaissance Technologies | 716,413 | $946,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
| Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |